MariMed Inc. (MRMD.CN)
| Previous Close | 0.6000 |
| Open | 0.0000 |
| Bid | 0.3100 x N/A |
| Ask | 7.9700 x N/A |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 4,773 |
| Market Cap | 210.803M |
| Beta (5Y Monthly) | 3.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
MariMed Announces Close on Acquisition of Ermont, Inc. Operating Assets
NORWOOD, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, and Ermont Inc. (“Ermont”) a vertically integrated medical cannabis operator located in Quincy, MA, today announced the close of MariMed’s transaction to acquire the operating assets of Ermont. The deal was previously announced on February 21, 2023. The acquisition marks the second medical dispensary for MariMed in Massachusetts, substa
- GlobeNewswire
MariMed Reports Fourth Quarter and Full Year 2022 Financial Results
NORWOOD, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and full year ended December 31, 2022. “I am pleased to report that our fourth quarter revenue grew sequentially and year-over-year as we continued to outperform the industry in all of our key states,” said Jon Levine, Chief Executive Office
- GlobeNewswire
MariMed Board of Directors Appoints Edward Gildea as Chairman and Jon Levine as Chief Executive Officer
NORWOOD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”), today announced its Board of Directors (the “Board”) has appointed Edward Gildea as Chairman of the Board and Jon Levine as Chief Executive Officer. Mr. Gildea has served as an independent director of the Company since 2013. Mr. Levine, co-founder and President of MariMed, has served as Interim CEO since the December passing of
